We highly recommend enabling Javascript while using the BlackBoxRX site.

Doravirine/Lamivudine/Tenofovir Disoproxil

Post-Treatment Acute Exacerbation of Hepatitis B

  • Severe acute exacerbations of hepatitis B (HBV) have been reported in patients coinfected with HIV-1 and HBV who have discontinued lamivudine or tenofovir disoproxil fumarate (TDF), two of the components of DELSTRIGO. Closely monitor hepatic function in these patients. If appropriate, initiation of antihepatitis B therapy may be warranted.

Patient Counseling Information

Package Inserts

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate

Updated September 2018